An ultra-low input, ultra-sensitive tumor-informed whole-genome sequencing-based minimal residual disease assay for solid tumors – Nathalia Graf Grachet

An ultra-low input, ultra-sensitive tumor-informed whole-genome sequencing-based minimal residual disease assay for solid tumors – Nathalia Graf Grachet | Nextflow Summit 2026

Ticketing questions

Program questions

Sponsorships